becomes clear to us as laypeople exactly what's happening inside the body when these, when people are taking these GLP-1s, then it might make more sense about why, as we'll talk about later, some people are saying I'm taking it for sleep apnea, and it's become a miracle drug, which may have little to do with diabetes
What the Research Shows About BPC-157 and Cancer The scientific literature on BPC-157 contains no studies demonstrating cancer promotion
2021 May 9 [cited 2025 Feb 17];9:2524
Third, Ohio Medicaid added narrow Wegovy criteria in April 2026 for MACE risk reduction and MASH (metabolic dysfunction-associated steatohepatitis), but standard weight-loss-only GLP-1 coverage remains unavailable on Ohio Medicaid
Saxenda, Wegovy, and Zepbound patients are included regardless of obesity diagnostic claims